• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于导管的射频肾去神经支配术后动态血压降低的解剖学和操作决定因素

Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.

作者信息

Lauder Lucas, Ewen Sebastian, Tzafriri Abraham R, Edelman Elazer R, Cremers Bodo, Kulenthiran Saarraaken, Ukena Christian, Linz Dominik, Kindermann Ingrid, Tsioufis Costas, Scheller Bruno, Böhm Michael, Mahfoud Felix

机构信息

Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Universität des Saarlandes, Homburg, Saar, Germany.

Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, Universität des Saarlandes, Homburg, Saar, Germany.

出版信息

Cardiovasc Revasc Med. 2018 Oct-Nov;19(7 Pt B):845-851. doi: 10.1016/j.carrev.2018.02.016. Epub 2018 Mar 2.

DOI:10.1016/j.carrev.2018.02.016
PMID:29555535
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6667167/
Abstract

BACKGROUND/PURPOSE: Catheter-based renal sympathetic denervation (RDN) has been introduced to lower blood pressure (BP) and sympathetic activity in patients with uncontrolled hypertension with at best equivocal results. It has been postulated that anatomic and procedural elements introduce unaccounted variability and yet little is known of the impact of renal anatomy and procedural parameters on BP response to RDN.

METHODS/MATERIALS: Anatomical parameters such as length and diameter were analyzed by quantitative vascular analysis and the prevalence of accessory renal arteries and renal artery disease were documented in 150 patients with resistant hypertension undergoing bilateral RDN using a mono-electrode radiofrequency catheter (Symplicity Flex, Medtronic).

RESULTS

Accessory renal arteries and renal artery disease were present in 56 (37%) and 14 patients (9%), respectively. At 6-months, 24 h-ambulatory BP was reduced by 11/6 mm Hg (p < 0.001 for both). Change of systolic blood pressure (SBP) was not related to the presence of accessory renal arteries (p = 0.543) or renal artery disease (p = 0.598). Patients with at least one main renal artery diameter ≤ 4 mm had a more pronounced reduction of 24 h-ambulatory SBP compared to patients where both arteries were >4 mm (-19 vs. -10 mmHg; p = 0.038). Neither the length of the renal artery nor the number of RF ablations influenced 24 h-ambulatory BP reduction at 6 months.

CONCLUSIONS

24 h-ambulatory BP lowering was most pronounced in patients with smaller renal artery diameter but not related to renal artery length, accessory arteries or renal artery disease. Further, there was no dose-response relationship observed with increasing number of ablations.

CONDENSED ABSTRACT

Because little is known of the impact of renal anatomy and procedural parameters on blood pressure (BP) response to renal denervation (RDN), anatomical and procedural data were analyzed in 150 patients undergoing bilateral RDN. BP lowering was most pronounced in patients with smaller renal artery diameter but not related to renal artery length, the presence of renal artery disease or accessory renal arteries. Further, there was no dose-response relationship observed with increasing number of ablations.

摘要

背景/目的:基于导管的肾交感神经去神经术(RDN)已被用于降低血压(BP)和交感神经活性,用于治疗难治性高血压患者,但结果充其量模棱两可。据推测,解剖学和操作因素会引入无法解释的变异性,然而,关于肾脏解剖结构和操作参数对RDN血压反应的影响知之甚少。

方法/材料:通过定量血管分析对长度和直径等解剖学参数进行分析,并记录了150例使用单电极射频导管(Symplicity Flex,美敦力公司)进行双侧RDN的难治性高血压患者的副肾动脉和肾动脉疾病的患病率。

结果

分别有56例(37%)和14例(9%)患者存在副肾动脉和肾动脉疾病。6个月时,24小时动态血压降低了11/6 mmHg(两者p均<0.001)。收缩压(SBP)的变化与副肾动脉的存在(p = 0.543)或肾动脉疾病(p = 0.598)无关。至少有一条主肾动脉直径≤4 mm的患者,其24小时动态SBP的降低比两条动脉直径均>4 mm的患者更明显(-19 vs. -10 mmHg;p = 0.038)。肾动脉长度和射频消融次数均未影响6个月时24小时动态血压的降低。

结论

肾动脉直径较小的患者24小时动态血压降低最为明显,但与肾动脉长度、副肾动脉或肾动脉疾病无关。此外,未观察到随着消融次数增加的剂量反应关系。

摘要

由于对肾脏解剖结构和操作参数对肾去神经术(RDN)血压反应的影响知之甚少,因此对150例接受双侧RDN的患者的解剖学和操作数据进行了分析。肾动脉直径较小的患者血压降低最为明显,但与肾动脉长度、肾动脉疾病或副肾动脉的存在无关。此外,未观察到随着消融次数增加的剂量反应关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a055/6667167/8398f36534b0/nihms-1030562-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a055/6667167/33d1cebd7ec2/nihms-1030562-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a055/6667167/2057994b8051/nihms-1030562-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a055/6667167/4a65125b7bac/nihms-1030562-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a055/6667167/8398f36534b0/nihms-1030562-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a055/6667167/33d1cebd7ec2/nihms-1030562-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a055/6667167/2057994b8051/nihms-1030562-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a055/6667167/4a65125b7bac/nihms-1030562-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a055/6667167/8398f36534b0/nihms-1030562-f0004.jpg

相似文献

1
Anatomical and procedural determinants of ambulatory blood pressure lowering following catheter-based renal denervation using radiofrequency.基于导管的射频肾去神经支配术后动态血压降低的解剖学和操作决定因素
Cardiovasc Revasc Med. 2018 Oct-Nov;19(7 Pt B):845-851. doi: 10.1016/j.carrev.2018.02.016. Epub 2018 Mar 2.
2
Anatomical and procedural determinants of catheter-based renal denervation.基于导管的肾去神经支配的解剖学和操作决定因素。
Cardiovasc Revasc Med. 2016 Oct-Nov;17(7):474-479. doi: 10.1016/j.carrev.2016.08.004. Epub 2016 Aug 20.
3
Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.采用标准电生理导管的药物抵抗性高血压的导管相关肾脏去神经术。
EuroIntervention. 2012 Jan;7(9):1077-80. doi: 10.4244/EIJV7I9A171.
4
Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation.副肾动脉:在顽固性高血压中的患病率及其在对肾动脉射频去神经术无反应中的重要作用。
Cardiovasc Revasc Med. 2016 Oct-Nov;17(7):470-473. doi: 10.1016/j.carrev.2016.07.009. Epub 2016 Jul 21.
5
Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.孤立性收缩期高血压中使用不同导管技术和技术的肾脏去神经支配。
Hypertension. 2019 Aug;74(2):341-348. doi: 10.1161/HYPERTENSIONAHA.119.13019. Epub 2019 Jun 17.
6
Procedural Reassessment of Radiofrequency Renal Denervation in Resistant Hypertensive Patients.顽固性高血压患者射频肾动脉去神经术的程序重新评估
High Blood Press Cardiovasc Prev. 2017 Jun;24(2):187-192. doi: 10.1007/s40292-017-0197-0. Epub 2017 Apr 3.
7
A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).一种随机三臂试验比较不同的肾动脉去神经术设备和技术在高血压抵抗患者中的应用(RADIOSOUND-HTN)。
Circulation. 2019 Jan 29;139(5):590-600. doi: 10.1161/CIRCULATIONAHA.118.037654.
8
Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.肾动脉解剖结构会影响顽固性高血压患者对肾去神经支配的血压反应。
Int J Cardiol. 2016 Jan 1;202:388-93. doi: 10.1016/j.ijcard.2015.09.015. Epub 2015 Sep 21.
9
Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.基于导管的肾去神经术对顽固性高血压患者心脏交感神经活动及神经支配的影响。
Clin Res Cardiol. 2016 Apr;105(4):364-71. doi: 10.1007/s00392-015-0930-4. Epub 2015 Oct 22.
10
Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.在耐药性高血压患者中,主肾动脉和主肾动脉加分支肾去神经支配的血压反应。
J Am Heart Assoc. 2017 Aug 10;6(8):e006196. doi: 10.1161/JAHA.117.006196.

引用本文的文献

1
Aspects of renal function and renal artery anatomy as indications for renal denervation.肾功能和肾动脉解剖学方面作为肾去神经术的适应证。
Hypertens Res. 2024 Oct;47(10):2711-2717. doi: 10.1038/s41440-024-01860-y. Epub 2024 Aug 29.
2
Present Evidence of Determinants to Predict the Efficacy of Renal Denervation.预测肾去神经支配疗效的决定因素的现有证据。
Int J Hypertens. 2022 Aug 12;2022:5694127. doi: 10.1155/2022/5694127. eCollection 2022.
3
Recent advances in managing primary hypertension.原发性高血压管理的最新进展

本文引用的文献

1
Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.在耐药性高血压患者中,主肾动脉和主肾动脉加分支肾去神经支配的血压反应。
J Am Heart Assoc. 2017 Aug 10;6(8):e006196. doi: 10.1161/JAHA.117.006196.
2
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.在未使用抗高血压药物的情况下,基于导管的肾脏去神经术治疗未控制的高血压患者(SPYRAL HTN-OFF MED):一项随机、假对照、概念验证试验。
Lancet. 2017 Nov 11;390(10108):2160-2170. doi: 10.1016/S0140-6736(17)32281-X. Epub 2017 Aug 28.
3
Fac Rev. 2020 Nov 4;9:4. doi: 10.12703/b/9-4. eCollection 2020.
4
Procedural and Anatomical Determinants of Multielectrode Renal Denervation Efficacy.多电极肾去神经术疗效的程序和解剖学决定因素。
Hypertension. 2019 Sep;74(3):546-554. doi: 10.1161/HYPERTENSIONAHA.119.12918. Epub 2019 Jul 15.
5
Renal Denervation: Is It Ready for Prime Time?肾去神经术:是否已准备好投入实际应用?
Curr Cardiol Rep. 2019 Jul 5;21(8):80. doi: 10.1007/s11886-019-1164-2.
Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future.
第二届欧洲高血压器械治疗临床共识会议纪要:现状与未来考量
Eur Heart J. 2017 Nov 21;38(44):3272-3281. doi: 10.1093/eurheartj/ehx215.
4
Anatomical and procedural determinants of catheter-based renal denervation.基于导管的肾去神经支配的解剖学和操作决定因素。
Cardiovasc Revasc Med. 2016 Oct-Nov;17(7):474-479. doi: 10.1016/j.carrev.2016.08.004. Epub 2016 Aug 20.
5
Accessory renal arteries: Prevalence in resistant hypertension and an important role in nonresponse to radiofrequency renal denervation.副肾动脉:在顽固性高血压中的患病率及其在对肾动脉射频去神经术无反应中的重要作用。
Cardiovasc Revasc Med. 2016 Oct-Nov;17(7):470-473. doi: 10.1016/j.carrev.2016.07.009. Epub 2016 Jul 21.
6
Adherence to Antihypertensive Medication in Treatment-Resistant Hypertension Undergoing Renal Denervation.接受肾去神经支配治疗的顽固性高血压患者对抗高血压药物的依从性
J Am Heart Assoc. 2016 Feb 12;5(2):e002343. doi: 10.1161/JAHA.115.002343.
7
Impact of Lesion Placement on Efficacy and Safety of Catheter-Based Radiofrequency Renal Denervation.基于导管的射频肾去神经术的病变位置对疗效和安全性的影响。
J Am Coll Cardiol. 2015 Oct 20;66(16):1766-1775. doi: 10.1016/j.jacc.2015.08.018.
8
Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.经导管肾去神经支配术后的血压降低与通过尿液/血浆毒理学分析测得的抗高血压药物依从性改善无关。
Clin Res Cardiol. 2015 Dec;104(12):1097-105. doi: 10.1007/s00392-015-0905-5. Epub 2015 Aug 26.
9
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design.欧洲肾脏去神经支配临床共识会议纪要:关于未来临床试验设计的思考
Eur Heart J. 2015 Sep 1;36(33):2219-27. doi: 10.1093/eurheartj/ehv192. Epub 2015 May 18.
10
Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension.随机假手术对照试验研究肾去交感神经术治疗轻度耐药性高血压。
Hypertension. 2015 Jun;65(6):1202-8. doi: 10.1161/HYPERTENSIONAHA.115.05283. Epub 2015 Mar 30.